ArticleMicrobiology spectrum2024

Ronapreve (REGN-CoV; casirivimab and imdevimab) reduces the viral burden and alters the pulmonary response to the SARS-CoV-2 Delta variant (B.1.617.2) in K18-hACE2 mice using an experimental design reflective of a treatment use case.

Lee Tatham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.